Lotus Pharmaceutical Co Ltd
TWSE:1795

Watchlist Manager
Lotus Pharmaceutical Co Ltd Logo
Lotus Pharmaceutical Co Ltd
TWSE:1795
Watchlist
Price: 282 TWD 0.18% Market Closed
Market Cap: 74.8B TWD
Have any thoughts about
Lotus Pharmaceutical Co Ltd?
Write Note

Lotus Pharmaceutical Co Ltd
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Lotus Pharmaceutical Co Ltd
Capital Expenditures Peer Comparison

Comparables:
Y
3705
4746
1789
S
4119
1720

Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
Lotus Pharmaceutical Co Ltd
TWSE:1795
Capital Expenditures
-NT$1.6B
CAGR 3-Years
-10%
CAGR 5-Years
-19%
CAGR 10-Years
-19%
Y
YungShin Global Holding Corp
TWSE:3705
Capital Expenditures
-NT$98.1m
CAGR 3-Years
25%
CAGR 5-Years
30%
CAGR 10-Years
10%
Formosa Laboratories Inc
TWSE:4746
Capital Expenditures
-NT$567.1m
CAGR 3-Years
0%
CAGR 5-Years
2%
CAGR 10-Years
0%
ScinoPharm Taiwan Ltd
TWSE:1789
Capital Expenditures
-NT$264.4m
CAGR 3-Years
-3%
CAGR 5-Years
-21%
CAGR 10-Years
16%
S
SCI Pharmtech Inc
TWSE:4119
Capital Expenditures
-NT$896.9m
CAGR 3-Years
-35%
CAGR 5-Years
-34%
CAGR 10-Years
-11%
Standard Chem & Pharm Co Ltd
TWSE:1720
Capital Expenditures
-NT$581m
CAGR 3-Years
-26%
CAGR 5-Years
-31%
CAGR 10-Years
-6%

See Also

What is Lotus Pharmaceutical Co Ltd's Capital Expenditures?
Capital Expenditures
-1.6B TWD

Based on the financial report for Jun 30, 2024, Lotus Pharmaceutical Co Ltd's Capital Expenditures amounts to -1.6B TWD.

What is Lotus Pharmaceutical Co Ltd's Capital Expenditures growth rate?
Capital Expenditures CAGR 10Y
-19%

Over the last year, the Capital Expenditures growth was 61%. The average annual Capital Expenditures growth rates for Lotus Pharmaceutical Co Ltd have been -10% over the past three years , -19% over the past five years , and -19% over the past ten years .

Back to Top